Antibody

Dallas-based company Vaxxinity, which uses synthetic peptides to develop a "safe and mild" COVID-19 vaccine along with vaccine therapies for several chronic diseases, plans to go public this Thursday under the NASDAQ symbol VAXX.…

As COVID-19 cases rise in North Texas and across the country, new monoclonal antibody treatments from Regeneron and other companies have come to the fore. Here's what preliminary research shows about these treatments.They are effective…

People at significant risk of developing severe COVID-19, including millions of Americans with compromised immune systems, now have the option to receive preventive treatment with monoclonal antibodies if they have been…